Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Ruian Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates multiple production lines compliant with international GMP standards, focusing on therapeutic areas such as cardiovascular health, anti-infectives, and gastrointestinal medicine. Its product portfolio includes several widely used statins and proton pump inhibitors, serving both domestic and international markets. Ruian Pharmaceutical provides contract manufacturing services alongside its proprietary product development, leveraging expertise in complex chemical synthesis. The company is headquartered in Heze, Shandong Province, and is recognized as a key player in the regional chemical-pharmaceutical industry. It maintains a strong commitment to quality control and technological innovation to support its global supply chain operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Ruian Pharmaceutical.